Recent Research on Gastrointestinal Carcinoma

by Giulia Rovesti, Giorgia Marisi, Andrea Casadei-Gardini
Published 2021-01-01

BRCA in Gastrointestinal Cancers: Current Treatments and Future Perspectives

by Eleonora Molinaro, Kalliopi Andrikou, Andrea Casadei-Gardini, Giulia Rovesti
Published 2020-11-01

The Growing Skyline of Advanced Hepatocellular Carcinoma Treatment: A Review

by Francesca Matilde Schipilliti, Ingrid Garajová, Giulia Rovesti, Rita Balsano, Federico Piacentini, Massimo Dominici, Fabio Gelsomino
Published 2021-01-01

Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy

by Panagiota Maravelia, Daniela Nascimento Silva, Giulia Rovesti, Michael Chrobok, Per Stål, Yong-Chen Lu, Anna Pasetto
Published 2021-08-01

Prognostic role of a new index (multi inflammatory index) in patients with metastatic colorectal cancer: results from the randomized ITACa trial

by Andrea Casadei Gardini, Emanuela Scarpi, Martina Valgiusti, Manlio Monti, Silvia Ruscelli, Laura Matteucci, Giulia Bartolini, Bernadette Vertogen, Flavia Pagan, Giulia Rovesti, Giovanni Luca Frassineti, Alessandro Passardi
Published 2020-09-01

¹H-NMR Based Serum Metabolomics Highlights Different Specific Biomarkers between Early and Advanced Hepatocellular Carcinoma Stages

by Andrea Casadei-Gardini, Laura Del Coco, Giorgia Marisi, Fabio Conti, Giulia Rovesti, Paola Ulivi, Matteo Canale, Giovanni Luca Frassineti, Francesco Giuseppe Foschi, Serena Longo, Francesco Paolo Fanizzi, Anna Maria Giudetti
Published 2020-01-01

Could Inflammatory Indices and Metabolic Syndrome Predict the Risk of Cancer Development? Analysis from the Bagnacavallo Population Study

by Margherita Rimini, Andrea Casadei-Gardini, Alessandra Ravaioli, Giulia Rovesti, Fabio Conti, Alberto Borghi, Anna Chiara Dall’Aglio, Giorgio Bedogni, Marco Domenicali, Pierluigi Giacomoni, Claudio Tiribelli, Lauro Bucchi, Fabio Falcini, Francesco Giuseppe Foschi, Bagnacavallo Study Group
Published 2020-04-01

<i>ANGPT2</i> and <i>NOS3</i> Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib

by Giorgia Marisi, Elisabetta Petracci, Francesco Raimondi, Luca Faloppi, Francesco Giuseppe Foschi, Gianfranco Lauletta, Massimo Iavarone, Matteo Canale, Martina Valgiusti, Luca Maria Neri, Paola Ulivi, Giulia Orsi, Giulia Rovesti, Ranka Vukotic, Fabio Conti, Alessandro Cucchetti, Giorgio Ercolani, Kalliopi Andrikou, Stefano Cascinu, Mario Scartozzi, Andrea Casadei-Gardini
Published 2019-07-01